Mieke Dewerchin

Mieke Dewerchin

Auto-generated profile, based on publicly available information

Mieke Dewerchin

Laboratory of Angiogenesis and Vascular Metabolism, Center for Cancer Biology (CCB), VIB and Department of Oncology, Leuven Cancer Institute (LKI), KU Leuven, Leuven, Belgium

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2018 in Cell Metabolism
Verified
Journal Article
Closed access
SVSaar Vandekeere
Saar Vandekeere
CDCharlotte DUBOIS
Charlotte DUBOIS
JKJoanna Kalucka
Joanna Kalucka
MSMark R. Sullivan
Mark R. Sullivan
Melissa García CaballeroMelissa García Caballero
Melissa García Caballero
PCPeter Carmeliet
Peter Carmeliet

20 September 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
VGVincent Geldhof
Vincent Geldhof
LRLaura P. M. H. de Rooij
Laura P. M. H. de Rooij
LSLiliana Sokol
Liliana Sokol
JAJacob Amersfoort
Jacob Amersfoort
MSMaxim De Schepper
Maxim De Schepper
PCPeter Carmeliet
Peter Carmeliet
Since a detailed inventory of endothelial cell (EC) heterogeneity in breast cancer (BC) is lacking, here we perform single cell RNA-sequencing of 26,515 cells (including 8433 ECs) from 9 BC patients and compare them to published EC taxonomies from lung tumors. Angiogenic ECs are phenotypically similar, while other EC subtypes are different. Predictive interactome analysis reveals known but also previously unreported receptor-ligand interactions between ECs and immune cells, suggesting an involvement of breast EC subtypes in immune responses. We also identify a capillary EC subtype (LIPEC (Lipid Processing EC)), which expresses genes involved in lipid processing that are regulated by PPAR-γ and is more abundant in peri-tumoral breast tissue. Retrospective analysis of 4648 BC patients reveals that treatment with metformin (an indirect PPAR-γ signaling activator) provides long-lasting clinical benefit and is positively associated with LIPEC abundance. Our findings warrant further exploration of this LIPEC/PPAR-γ link for BC treatment.

12 July 2019 in Nature Metabolism
Verified
Journal Article
Closed access
PDF file
Melissa García CaballeroMelissa García Caballero
Melissa García Caballero
AZAnnalisa Zecchin
Annalisa Zecchin
JSJoris Souffreau
Joris Souffreau
ATAnh-Co Khanh Truong
Anh-Co Khanh Truong
LTLaure-Anne Teuwen
Laure-Anne Teuwen
PCPeter Carmeliet
Peter Carmeliet

11 May 2020 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
FTFederico Taverna
Federico Taverna
JGJermaine Goveia
Jermaine Goveia
TKTobias K Karakach
Tobias K Karakach
SKShawez Khan
Shawez Khan
KRKaterina Rohlenova
Katerina Rohlenova
PCPeter Carmeliet
Peter Carmeliet
The amount of biological data, generated with (single cell) omics technologies, is rapidly increasing, thereby exacerbating bottlenecks in the data analysis and interpretation of omics experiments. Data mining platforms that facilitate non-bioinformatician experimental scientists to analyze a wide range of experimental designs and data types can alleviate such bottlenecks, aiding in the exploration of (newly generated or publicly available) omics datasets. Here, we present BIOMEX, a browser-based software, designed to facilitate the Biological Interpretation Of Multi-omics EXperiments by bench scientists. BIOMEX integrates state-of-the-art statistical tools and field-tested algorithms into a flexible but well-defined workflow that accommodates metabolomics, transcriptomics, proteomics, mass cytometry and single cell data from different platforms and organisms. The BIOMEX workflow is accompanied by a manual and video tutorials that provide the necessary background to navigate the interface and get acquainted with the employed methods. BIOMEX guides the user through omics-tailored analyses, such as data pretreatment and normalization, dimensionality reduction, differential and enrichment analysis, pathway mapping, clustering, marker analysis, trajectory inference, meta-analysis and others. BIOMEX is fully interactive, allowing users to easily change parameters and generate customized plots exportable as high-quality publication-ready figures. BIOMEX is open source and freely available at https://www.vibcancer.be/software-tools/biomex.

19 May 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
OMOdeta Meçe
Odeta Meçe
DHDiede Houbaert
Diede Houbaert
MSMaria-Livia Sassano
Maria-Livia Sassano
TDTania Durré
Tania Durré
HMHannelore Maes
Hannelore Maes
PAPatrizia Agostinis
Patrizia Agostinis
Autophagy has vasculoprotective roles, but whether and how it regulates lymphatic endothelial cells (LEC) homeostasis and lymphangiogenesis is unknown. Here, we show that genetic deficiency of autophagy in LEC impairs responses to VEGF-C and injury-driven corneal lymphangiogenesis. Autophagy loss in LEC compromises the expression of main effectors of LEC identity, like VEGFR3, affects mitochondrial dynamics and causes an accumulation of lipid droplets (LDs) in vitro and in vivo. When lipophagy is impaired, mitochondrial ATP production, fatty acid oxidation, acetyl-CoA/CoA ratio and expression of lymphangiogenic PROX1 target genes are dwindled. Enforcing mitochondria fusion by silencing dynamin-related-protein 1 (DRP1) in autophagy-deficient LEC fails to restore LDs turnover and lymphatic gene expression, whereas supplementing the fatty acid precursor acetate rescues VEGFR3 levels and signaling, and lymphangiogenesis in LEC-Atg5−/− mice. Our findings reveal that lipophagy in LEC by supporting FAO, preserves a mitochondrial-PROX1 gene expression circuit that safeguards LEC responsiveness to lymphangiogenic mediators and lymphangiogenesis.

14 September 2021 in STAR Protocols
Verified
Journal Article
Open access
NCNadine V. Conchinha
Nadine V. Conchinha
LSLiliana Sokol
Liliana Sokol
LTLaure-Anne Marie Nicole Teuwen
Laure-Anne Marie Nicole Teuwen
KVKoen Veys
Koen Veys
SDSébastien J. Dumas
Sébastien J. Dumas
PCPeter Carmeliet
Peter Carmeliet
Endothelial cells (ECs) harbor distinct phenotypical and functional characteristics depending on their tissue localization and contribute to brain, eye, lung, and muscle diseases such as dementia, macular degeneration, pulmonary hypertension, and sarcopenia. To study their function, isolation of pure ECs in high quantities is crucial. Here, we describe protocols for rapid and reproducible blood vessel EC purification established for scRNA sequencing from murine tissues using mechanical and enzymatic digestion followed by magnetic and fluorescence-activated cell sorting.